These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10778237)

  • 1. [KL-6 antigen].
    Kitamura S
    Nihon Rinsho; 1999 Dec; 57 Suppl():772-5. PubMed ID: 10778237
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of serum KL-6 in diagnosis of interstitial pneumonia complicated with collagen disease].
    Harigai M
    Nihon Naika Gakkai Zasshi; 2003 Oct; 92(10):1985-9. PubMed ID: 14621589
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
    Kohno N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
    Kohno N
    J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis.
    Kobayashi I; Ono S; Kawamura N; Okano M; Miyazawa K; Shibuya H; Kobayashi K
    J Pediatr; 2001 Feb; 138(2):274-6. PubMed ID: 11174630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
    Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
    Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
    Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Establishment of reference intervals and cut-off value by an enzyme immunoassay for KL-6 antigen, a new marker for interstitial pneumonia].
    Kobayashi J; Itoh Y; Kitamura S; Kawai T
    Rinsho Byori; 1996 Jul; 44(7):653-8. PubMed ID: 8801361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interstial pneumonia, which activity was reflected on KL-6, associated with dermatomyositis successfully treated with cyclosporin A].
    Niinaka M; Matsui K; Aizawa N; Tominaga K; Iida S; Nakano T; Hada T
    Arerugi; 2003 Jul; 52(7):586-90. PubMed ID: 12928607
    [No Abstract]   [Full Text] [Related]  

  • 10. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
    Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
    Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KL-6, a mucinous glycoprotein, as an indicator of chronic lung disease of the newborn.
    Ogihara T; Hirano K; Morinobu T; Ogawa S; Hiroi M; Ban R; Ogihara H; Tamai H
    J Pediatr; 2000 Aug; 137(2):280-2. PubMed ID: 10931429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
    Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
    J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How can we monitor and treat patients with acute exacerbations of idiopathic interstitial pneumonia].
    Kobayashi J; Kitamura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():195-9. PubMed ID: 9216215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KL-6, a human MUC1 mucin, promotes proliferation and survival of lung fibroblasts.
    Ohshimo S; Yokoyama A; Hattori N; Ishikawa N; Hirasawa Y; Kohno N
    Biochem Biophys Res Commun; 2005 Dec; 338(4):1845-52. PubMed ID: 16289035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CA19-9-producing idiopathic pulmonary fibrosis with diffuse alveolar damage and a high titer of KL-6--an autopsy case].
    Shimizu Y; Tanaka Y; Sasaki A; Nemoto T
    Nihon Kokyuki Gakkai Zasshi; 2001 May; 39(5):351-6. PubMed ID: 11510099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of Wilson-Mikity syndrome with high serum KL-6 levels.
    Takami T; Kumada A; Takei Y; Miyajima T; Hoshika A
    J Perinatol; 2003 Jan; 23(1):56-8. PubMed ID: 12556928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
    Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
    Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KL-6: a serum marker for interstitial pneumonia.
    Kobayashi J; Kitamura S
    Chest; 1995 Aug; 108(2):311-5. PubMed ID: 7634858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sialylated carbohydrate antigen KL-6].
    Kohno N
    Nihon Rinsho; 2004 Nov; 62 Suppl 11():321-4. PubMed ID: 15628407
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia.
    Yokoyama A; Kohno N; Kondo K; Ueda S; Hirasawa Y; Watanabe K; Takada Y; Hiwada K
    Respirology; 1998 Sep; 3(3):199-202. PubMed ID: 9767620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.